HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide
0.1.0 - CI Build

HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions

## Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

### Behavior: Capability Statements

The following artifacts define the specific capabilities that different types of systems are expected to have in order to comply with this implementation guide. Systems conforming to this implementation guide are expected to declare conformance to one or more of the following capability statements.

CapabilityStatement | Represents API exposed to retrieve plans

### Structures: Logical Models

These define data models that represent the domain covered by this implementation guide in more business-friendly terms than the underlying FHIR resources.

CancerRegimensLM | CancerRegimens

### Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

ActivityDefinition | CCA Regimen Activity Definition.
PlanDefinition | CCA Regimen Plan Definition.

### Structures: Data Type Profiles

These define constraints on FHIR data types for systems conforming to this implementation guide.

Dosage | CCA Regimen Dosage.

### Structures: Extension Definitions

These define constraints on FHIR data types for systems conforming to this implementation guide.

AdditionalDetails | Allows additional information to be added to a regimen such as dosing modification details
Disclaimer | A disclaimer for use of this Plan
ESMO-MCBS Score | The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) score for the regimen
Instructions for use | Specific instructions for use of the regimen overall, or for the individual cycles
LocationAdministration | The physical Location where the medication administration occurs (eg home or clinic)
LocationMedicationCollection | The physical Location where the medication can be collection prior to collection
Off label | Indicates that the medication is being used for a purpose for which it has not been specifically approved
Regimen type | The overall type of the regimen - eg FOLFOX
Regimen under review | Additional status values for PlanDefinition. Currently only a single value - review - indicating that a regimen is published and available to be used, but there is still a review being performed, so could change. In most situations the value of the status element itself will be 'active'
Replaced by | When a Plan has been deprecated (superceeded or discontinued), refers to the one that replaces it, if any
SupportFactor | Support factors needed during treatment
TimingOfDays | Allows specific days to be indicated in a component of a regimen cycle. extends the idea of UV extension: http://hl7.org/fhir/extension-timing-daysofcycle.html by adding instructions
TreatmentSetting | The setting of the regimen - what is its purpose

### Terminology: Value Sets

These define sets of codes used by systems conforming to this implementation guide.

Administration location | The physical location where the administration occurred - eg at home or in a clinic
Cancer type | The type of Cancer
ESMO-MCBS Evaluation Form | The evaluation forms used in the ESMO Magnitude of Clinical Benefit Scale
Medication collection location | The physical location where the medication can be collected on prior to administration - eg a pharmacy
Medication dose administration frequency | The dose administration frequency
Medication dose unit | The dose unit
PlanDefinition additional status | Other codes used for the PlanDefinition status
Possible values for Support Factors | The set of all possible support factors values (not specific to any one factor)
Regimen type code | The type of regimen - eg FOLFOX
Route | Route
Support Factors | The set of possible support factors (not their values)
Treatment setting | The setting of the regimen - what is its purpose

### Terminology: Code Systems

These define new code systems used by systems conforming to this implementation guide.

ESMO-MCBS Evaluation Form | The evaluation forms used in the ESMO Magnitude of Clinical Benefit Scale
PlanDefinition additional status | Other codes used for the PlanDefinition status
Regimen type code | Codes used for the regimen type
Treatment setting | The setting of the regimen - what is its purpose

### Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

ActCabergoline | Cabergoline Administration
ActTragacanth | Tragacanth Administration
Colorectal Adjuvant FOLFOX (a7) | Example Plan definition for coloRectal cancer
GU PROS Castration resistant Metastatic - abiraterone and dexamethasone | A drug treatment regimen for Urogenital Prostate Castration resistant Metastatic - abiraterone and dexamethasone
GYN END Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel | A drug treatment regimen for Gynaecological Endometrial Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel
LUNG NSCLC Metastatic - alectinib | A drug treatment regimen for Respiratory Non small cell lung cancer Metastatic - alectinib
LUNG NSCLC NON-Metastatic - alectinib | A drug treatment regimen for Respiratory Non small cell lung cancer NON-Metastatic - alectinib
SuperceededPlan | A plan that has been superceeded by another